Clinical Study on Chinese Children's Asthma Action Plan

NCT03435822 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2018-03-20

No results posted yet for this study

Summary

This study is a multi-center randomized controlled trial of children with asthma. The objective of the study is to assess the efficacy of China Children Asthma Action Plan (CCAAP), which is the first asthma action plan for children with asthma in China, in asthma management.

Conditions

  • Asthma in Children

Interventions

OTHER

asthma action plan management group

Patients will follow the directions in asthma action plan when their asthma get worse.

OTHER

conventional management group

Patients will follow the directions in conventional strategy when their asthma get worse.

Sponsors & Collaborators

  • Tian Jing Children's Hospital

    collaborator UNKNOWN
  • Capital Institute of Pediatrics, China

    collaborator OTHER
  • Peking University Third Hospital

    collaborator OTHER
  • Beijing Tsinghua Chang Gung Hospital

    collaborator OTHER
  • Tianjin Medical University Second Hospital

    collaborator OTHER
  • Peking University Bin Hai Hospital

    collaborator UNKNOWN
  • The First Hospital of Qinhuangdao

    collaborator OTHER_GOV
  • Tangshan Maternal and Child Health Hospital

    collaborator OTHER
  • Children's Hospital of Hebei Province

    collaborator OTHER
  • Beijing Children's Hospital

    lead OTHER

Principal Investigators

  • kunling Shen, MD,PhD · Beijing Children's Hospital of Capital Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-22
Primary Completion
2019-06-30
Completion
2019-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03435822 on ClinicalTrials.gov